New Opportunities for Targeting the Androgen Receptor in Prostate Cancer

Margaret M. Centenera, Luke A. Selth, Esmaeil Ebrahimie, Lisa Butler, Wayne D. Tilley

Research output: Contribution to journalReview article


Recent genomic analyses of metastatic prostate cancer have provided important insight into adaptive changes in androgen receptor (AR) signaling that underpin resistance to androgen deprivation therapies. Novel strategies are required to circumvent these AR-mediated resistance mechanisms and thereby improve prostate cancer survival. In this review, we present a summary of AR structure and function and discuss mechanisms of AR-mediated therapy resistance that represent important areas of focus for the development of new therapies.

Original languageEnglish
JournalCold Spring Harbor perspectives in medicine
Issue number12
Publication statusPublished - 3 Dec 2018


  • Journal Article
  • Review

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this